MorphoSys AG Short Interest Down 13.3 percent in April
Slightly above 67% of MorphoSys' investor base is looking to short. The analysis of current outlook of investing in MorphoSys AG ADR suggests that many traders are alarmed regarding MorphoSys' prospects. MorphoSys' investing sentiment overview a quick insight into current market opportunities from investing in MorphoSys AG ADR. Many technical investors use MorphoSys AG ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MorphoSys |
MorphoSys AG was the recipient of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 28,700 shares, a drop of 13.3 percent from the March 31st total of 33,100 shares. Based on an average trading volume of 111,400 shares, the days-to-cover
Read at thelincolnianonline.com
 |
MorphoSys Fundamental Analysis
We analyze MorphoSys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MorphoSys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MorphoSys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
MorphoSys is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
MorphoSys AG ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MorphoSys stock to make a market-neutral strategy. Peer analysis of MorphoSys could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics with similar companies.
Peers
MorphoSys Related Equities
| GOSS | Gossamer Bio | 3.53 | ||||
| RLYB | Rallybio Corp | 3.23 | ||||
| IMCR | Immunocore Holdings | 1.62 | ||||
| PCVX | Vaxcyte | 1.26 | ||||
| REPL | Replimune | 0.57 | ||||
| ELVN | Enliven Therapeutics | 0.09 | ||||
| CGEM | Cullinan Oncology | 0.16 | ||||
| GLUE | Monte Rosa | 0.57 | ||||
| PMVP | Pmv Pharmaceuticals | 0.67 | ||||
| GBIO | Generation Bio | 0.93 | ||||
| EWTX | Edgewise Therapeutics | 1.33 | ||||
| NVCT | Nuvectis Pharma | 1.53 | ||||
| MLYS | Mineralys Therapeutics, | 1.68 | ||||
| VTYX | Ventyx Biosciences | 1.79 | ||||
| KRON | Kronos Bio | 2.06 | ||||
| ACLX | Arcellx | 2.12 | ||||
| IMRX | Immuneering Corp | 3.43 | ||||
| IPSC | Century Therapeutics | 3.85 | ||||
| CCCC | C4 Therapeutics | 3.96 | ||||
| LYRA | Lyra Therapeutics | 4.55 | ||||
| MRSN | Mersana Therapeutics | 5.33 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in MorphoSys Stock
If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |